These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 17656174

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. New contraceptive methods.
    Plourd DM, Rayburn WF.
    J Reprod Med; 2003 Sep; 48(9):665-71. PubMed ID: 14562628
    [Abstract] [Full Text] [Related]

  • 26. [Use of contraceptives in Norway in 2005].
    Skjeldestad FE.
    Tidsskr Nor Laegeforen; 2007 Nov 01; 127(21):2803-5. PubMed ID: 17987070
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The transdermal patch and the vaginal ring: two novel methods of combined hormonal contraception.
    Swica Y.
    Obstet Gynecol Clin North Am; 2007 Mar 01; 34(1):31-42, viii. PubMed ID: 17472863
    [Abstract] [Full Text] [Related]

  • 29. Profile of long-acting reversible contraception users in Europe.
    Haimovich S.
    Eur J Contracept Reprod Health Care; 2009 Jun 01; 14(3):187-95. PubMed ID: 19565416
    [Abstract] [Full Text] [Related]

  • 30. Contraceptive vaginal ring use for women has less adverse metabolic effects than an oral contraceptive.
    Elkind-Hirsch KE, Darensbourg C, Ogden B, Ogden LF, Hindelang P.
    Contraception; 2007 Nov 01; 76(5):348-56. PubMed ID: 17963858
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Documented short-term continuation rates for combined hormonal contraceptives in an indigent population with ready access to contraceptive supplies.
    Nelson AL, Pietersz D, Nelson LE, Aguilera L.
    Am J Obstet Gynecol; 2007 Jun 01; 196(6):599.e1-5; discussion 599.e5-6. PubMed ID: 17547913
    [Abstract] [Full Text] [Related]

  • 36. Oral and transdermal hormonal contraception in women after kidney transplantation.
    Pietrzak B, Bobrowska K, Jabiry-Zieniewicz Z, Kaminski P, Wielgos M, Pazik J, Durlik M.
    Transplant Proc; 2007 Nov 01; 39(9):2759-62. PubMed ID: 18021980
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of factors associated with noncompliance in users of combined hormonal contraceptive methods: a cross-sectional study: results from the MIA study.
    Martínez-Astorquiza-Ortiz de Zarate T, Díaz-Martín T, Martínez-Astorquiza-Corral T, MIA Study Investigators.
    BMC Womens Health; 2013 Oct 20; 13():38. PubMed ID: 24138751
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The contraceptive vaginal ring compared with the combined oral contraceptive pill: a comprehensive review of randomized controlled trials.
    Roumen FJ.
    Contraception; 2007 Jun 20; 75(6):420-9. PubMed ID: 17519147
    [Abstract] [Full Text] [Related]

  • 40. Depo-Provera: use of a long-acting progestin injectable contraceptive in Turkish women.
    Aktun H, Moroy P, Cakmak P, Yalcin HR, Mollamahmutoglu L, Danisman N.
    Contraception; 2005 Jul 20; 72(1):24-7. PubMed ID: 15964288
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.